Annie Wu
About Annie Wu
Annie Wu serves as the Head of Finance for Brii Biosciences in China, a position she has held since 2018. She specializes in enhancing internal controls and developing efficient financial processes, drawing on extensive experience in various industries, including pharmaceuticals and automotive manufacturing.
Work at Brii Biosciences
Annie Wu has served as the Head of Finance for Brii Biosciences in China since 2018. In this role, she has focused on improving internal controls and establishing efficient financial processes. She played a significant role in building the finance capabilities of the organization from the ground up, ensuring that the financial operations align with the company's strategic goals.
Education and Expertise
Annie Wu holds a Bachelor's degree in International Trade from Shanghai University of Finance and Economics, where she studied from 1995 to 1999. She furthered her education by obtaining an MBA from Carleton University. Her academic background supports her expertise in finance and business dynamics across various industries.
Background
Annie Wu began her career as an auditor at EY from 1999 to 2002. She then transitioned to GSK, where she worked for ten years as Finance Director for Vaccines, HIV, and Dermatology from 2008 to 2018. Prior to her tenure at GSK, she served as a SOX champion at TRW from 2005 to 2008, gaining valuable experience in compliance and internal controls.
Achievements
Throughout her career, Annie Wu has developed extensive experience in setting up business models and strategies that support organizational growth. Her deep understanding of business dynamics spans various sectors, including automotive manufacturing and pharmaceuticals, which enhances her effectiveness in financial leadership roles.